2020
DOI: 10.1016/j.ejmg.2020.103877
|View full text |Cite
|
Sign up to set email alerts
|

Previously undescribed phenotypic findings and novel ACTG1 gene pathogenic variants in Baraitser-Winter cerebrofrontofacial syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 23 publications
0
7
0
1
Order By: Relevance
“…Just as ACTG1 variants leading to DFNA20/26, those leading to BWCFF syndrome most probably determine a gain-of-function effect [6,7], but the exact pathogenic mechanism is yet to be clarified. Anyway, the spectrum of pathogenic variants observed in patients with DFNA20/26 does not overlap with the one observed in patients with a typical BWCFF syndrome (Supplementary Tables S2 and S3) [6,7,[47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66]. In addition, the results of preliminary studies with lymphoblastoid cell lines from BWCFF syndrome patients, as well as the results of in vitro and in vivo studies on DFNA20/26-associated variants, suggest that the phenotypic impact of missense mutations may differ in a mutation-specific way; the available functional studies highlighted that each ACTG1 variant led to specific alterations in terms of actin organization and polymerization, interaction with actin-binding proteins, and cell morphology [4,6,7,19,[43][44][45][46].…”
Section: Discussionmentioning
confidence: 92%
“…Just as ACTG1 variants leading to DFNA20/26, those leading to BWCFF syndrome most probably determine a gain-of-function effect [6,7], but the exact pathogenic mechanism is yet to be clarified. Anyway, the spectrum of pathogenic variants observed in patients with DFNA20/26 does not overlap with the one observed in patients with a typical BWCFF syndrome (Supplementary Tables S2 and S3) [6,7,[47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66]. In addition, the results of preliminary studies with lymphoblastoid cell lines from BWCFF syndrome patients, as well as the results of in vitro and in vivo studies on DFNA20/26-associated variants, suggest that the phenotypic impact of missense mutations may differ in a mutation-specific way; the available functional studies highlighted that each ACTG1 variant led to specific alterations in terms of actin organization and polymerization, interaction with actin-binding proteins, and cell morphology [4,6,7,19,[43][44][45][46].…”
Section: Discussionmentioning
confidence: 92%
“…Cerebellar vermis hypoplasia without cerebral cortex abnormalities is undescribed features of BWS. Cerebellar vermis hypoplasia has been reported in two previous BWS patients harboring ACTG1 (p.Thr203Met) variants, with abnormalities of corpus callosum, heterotopia, and pachygyria (Vontell et al ., 2019; Chacon-Camacho et al ., 2020). More than 80% of patients have supratentorial abnormalities, including frontal lobe-dominant pachygyria, heterotopia, and corpus callosum hypoplasia (Rossi et al ., 2003).…”
Section: Discussionmentioning
confidence: 99%
“…Great phenotypic variability can be observed for ACTG1 carriers even within the same family (Kemerley et al, 2017). As for other rare diseases, the original definition of BRWS syndrome does not well adapt to the clinical presentation of several ACTB or ACTG1 carriers, with some authors referring to such cases as atypical BRWS (Johnston et al, 2013), others invoking a phenotypic expansion (Dawidziuk et al, 2022) which progressively enriches with new findings (Chacon‐Camacho et al, 2020), or talking about a pleiotropic developmental disorder (Cuvertino et al, 2017) with hypervariable expression (Dawidziuk et al, 2022).…”
Section: Discussionmentioning
confidence: 99%